Skip to main content
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.345
-0.004 (-1.03%)
At close: Apr 28, 2026, 4:00 PM EDT
0.350
+0.005 (1.48%)
Pre-market: Apr 29, 2026, 7:00 AM EDT

Gossamer Bio Revenue

In the year 2025, Gossamer Bio had annual revenue of $48.47M, down -57.74%. Gossamer Bio had revenue of $13.80M in the quarter ending December 31, 2025, with 47.13% growth.

Revenue (ttm)
$48.47M
Revenue Growth
-57.74%
P/S Ratio
1.67
Revenue / Employee
$299,204
Employees
162
Market Cap
80.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202548.47M-66.23M-57.74%
Dec 31, 2024114.70M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Q32 Bio 53.74M
Sangamo Therapeutics 39.55M
Pelthos Therapeutics 16.80M
Alterity Therapeutics 4.43M
aTyr Pharma 190.00K
Revenue Rankings

GOSS News

More News